The Vanguard Group 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 3:50 pm Unchanged |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
The Vanguard Group | 510,299 6.130% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:49 am Sale |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
The Vanguard Group | 510,299 6.130% |
-70,378 (-12.12%) |
Filing |
| 2024-02-13 5:07 pm Purchase |
2023-12-29 | 13G | Karyopharm Therapeutics Inc. KPTI |
The Vanguard Group | 580,677 7.600% |
580,677 (New Position) |
Filing |